CRISPR-Cas-Based Editing Technologies in Preclinical Models for Disease Correction

<p>Genome editing technologies for disease correction are advancing, driven by advances in foundational tools such as CRISPR-Cas, protein engineering, and artificial intelligence. This has led to CRISPR-Cas-derived technologies, known as nuclease editors, base editors, and prime editors, which work...

Descripción completa

Detalles Bibliográficos

Autores principales:	Karki, Prakriti, GC, Sudarshan
Formato:	Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2026
Materias:	Life Sciences
Acceso en línea:	https://www.intechopen.com/chapters/1245160
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!